Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
- PMID: 38301687
- DOI: 10.1016/S1470-2045(23)00516-8
Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
Conflict of interest statement
BG receives salary support from the Ontario Institute for Cancer Research funded by the Government of Ontario. The views expressed in the publication are the views of the authors and do not necessarily reflect those of the Government of Ontario. BG has received consulting fees from Vivio Health, unrelated to the manuscript. CMB declares no competing interests. We gratefully acknowledge Rachel Koven (patient advocate) for her input on an early draft of this Essay; she was not compensated for her contributions.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical